Michael Halpin sold $495K of Vericel (VCEL)

Executed Mar 3 2025, disclosed Mar 5 2025, 2 days later.

Value, as filed

$495K

10,000 sh × $49.52

Executed

Mar 3 2025

the trade date, as filed

Disclosed

Mar 5 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael Halpin Chief Operating Officer profile →

Michael Halpin (Chief Operating Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Vericel Corporation (VCEL). The largest single filing was $468K of VCEL (10,000 sh × $46.84, as filed), executed Aug 3.

The name

VCEL

Vericel Corporation VCEL · Healthcare · 46 filings in 24 months ticker →

Healthcare · Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael Halpin in VCEL

VCELSALE Vericel Corporation $468K
10,000 sh × $46.84
Exec Aug 3
Filed Aug 5 · 4:05 PM ET VCELSALE Vericel Corporation $402K
10,000 sh × $40.24
Exec Jun 18
Filed Jun 22 · 5:30 PM ET VCELSALE Vericel Corporation $364K
10,305 sh × $35.30
Exec Mar 2
Filed Mar 4 · 5:30 PM ET VCELSALE Vericel Corporation $405K
10,000 sh × $40.48
Exec Jan 7
Filed Jan 9 · 5:30 PM ET VCELSALE Vericel Corporation $107K
2,642 sh × $40.41
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET VCELSALE Vericel Corporation $298K
7,358 sh × $40.47
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET